HRSA/OPA announced the withdrawal of the so-called mega rule last November.  This major piece of legislative rulemaking had been over four years in the works.  The rule had spent the past six months at the Office of Management and Budget, the last step prior to publication.  The DC District Court ruling in Pharmaceutical Research and … Continue Reading